Grown Rogue International (GRUSF) Retained Earnings (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Retained Earnings of -$121906.0 for Q1 2026, up 99.62% year-over-year from -$61069.9 in Q1 2025, and little changed quarter-over-quarter from -$121906.0 in Q4 2025.
Grown Rogue International (GRUSF) Retained Earnings (2009 - 2026) Analysis & Trends
Grown Rogue International's Retained Earnings history runs 18 years deep, the most recent figure standing at -$121906.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.62% year-over-year to -$121906.0; the TTM figure through Mar 2026 stood at -$121906.0 (up 99.62% YoY), while the FY2025 annual figure was -$121906.0, up 3.2% from the prior year.
- Retained Earnings for Q1 2026 stood at -$121906.0, roughly flat from -$121906.0 in the prior quarter.
- The five-year high for Retained Earnings was $8.1 million in Q4 2023, with the low at -$27754.9 billion in Q3 2025.
- The 5-year median for Retained Earnings is -$17.8 million (2023), against an average of -$1982.5 billion.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings surged 150.26% in 2023, then plunged 108533437.45% in 2025.
- Grown Rogue International's Retained Earnings stood at -$16.1 million in 2022, then gained by 7.02% to -$15.0 million in 2023, then soared by 99.16% to -$125930.0 in 2024, then climbed by 3.2% to -$121906.0 in 2025, then changed by 0.0% to -$121906.0 in 2026.
- Business Quant data shows GRUSF's Retained Earnings at -$121906.0 in Q1 2026, -$121906.0 in Q4 2025, and -$27754.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn | -45.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45.96 Mn |
| Mar 31, 2026 | -121,906.00 |
| Dec 31, 2025 | -121,906.00 |
| Sep 30, 2025 | -27,754.87 Bn |
| Jun 30, 2025 | -30.52 Mn |
| Mar 31, 2025 | -31.84 Mn |
| Dec 31, 2024 | -125,930.00 |
| Sep 30, 2024 | -25.57 Mn |
| Jun 30, 2024 | -25.43 Mn |
| Mar 31, 2024 | -24.55 Mn |
| Dec 31, 2023 | -14.95 Mn |
| Oct 31, 2023 | 8.08 Mn |
| Jul 31, 2023 | -14.15 Mn |
| Jan 31, 2023 | -19.53 Mn |
| Oct 31, 2022 | -16.08 Mn |
| Oct 31, 2021 | -21.80 Mn |
| Apr 30, 2021 | -21.74 Mn |
| Jan 31, 2021 | -20.39 Mn |
| Oct 31, 2020 | 4.07 Mn |
| Jul 31, 2020 | -19.31 Mn |